Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Net Cash Flow (2016 - 2026)

Skinvisible's Net Cash Flow history spans 16 years, with the latest figure at $1975.0 for Q4 2025.

  • On a quarterly basis, Net Cash Flow fell 79.69% to $1975.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$3629.0, a 119.44% decrease, with the full-year FY2025 number at -$7716.0, down 181.67% from a year prior.
  • Net Cash Flow hit $1975.0 in Q4 2025 for Skinvisible, up from $525.0 in the prior quarter.
  • Over the last five years, Net Cash Flow for SKVI hit a ceiling of $164543.0 in Q2 2022 and a floor of -$52240.0 in Q1 2023.
  • Historically, Net Cash Flow has averaged $366.65 across 5 years, with a median of -$2330.0 in 2023.
  • Biggest five-year swings in Net Cash Flow: tumbled 539.86% in 2021 and later surged 6093.63% in 2024.
  • Tracing SKVI's Net Cash Flow over 5 years: stood at $16814.0 in 2021, then crashed by 373.79% to -$46035.0 in 2022, then soared by 100.34% to $157.0 in 2023, then surged by 6093.63% to $9724.0 in 2024, then tumbled by 79.69% to $1975.0 in 2025.
  • Business Quant data shows Net Cash Flow for SKVI at $1975.0 in Q4 2025, $525.0 in Q3 2025, and -$9189.0 in Q2 2025.